Bette Caan to Cardiovascular Diseases
This is a "connection" page, showing publications Bette Caan has written about Cardiovascular Diseases.
Connection Strength
2.091
-
Adipose Tissue Distribution and Cardiovascular Disease Risk Among Breast Cancer Survivors. J Clin Oncol. 2019 10 01; 37(28):2528-2536.
Score: 0.447
-
Adiposity, post-diagnosis weight change, and risk of cardiovascular events among early-stage breast cancer survivors. Breast Cancer Res Treat. 2017 04; 162(3):549-557.
Score: 0.376
-
Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer. J Clin Oncol. 2016 08 10; 34(23):2743-9.
Score: 0.358
-
Pre-diagnosis lipid levels and mortality after obesity-related cancer diagnosis in the Women's Health Initiative cardiovascular disease biomarker cohort. Cancer Med. 2023 08; 12(15):16626-16636.
Score: 0.146
-
Association between dietary inflammatory potential and mortality after cancer diagnosis in the Women's Health Initiative. Br J Cancer. 2023 Feb; 128(4):606-617.
Score: 0.141
-
Association of Normal-Weight Central Obesity With All-Cause and Cause-Specific Mortality Among Postmenopausal Women. JAMA Netw Open. 2019 07 03; 2(7):e197337.
Score: 0.111
-
Body Composition and Cardiovascular Events in Patients With Colorectal Cancer: A Population-Based Retrospective Cohort Study. JAMA Oncol. 2019 Jul 01; 5(7):967-972.
Score: 0.111
-
Mortality and cardiac and vascular outcomes in extremely obese women. JAMA. 2006 Jul 05; 296(1):79-86.
Score: 0.090
-
Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med. 2005 Mar 14; 165(5):500-8.
Score: 0.082
-
Implications of obesity for cardiovascular disease in blacks: the CARDIA and ARIC studies. Am J Clin Nutr. 1991 06; 53(6 Suppl):1604S-1611S.
Score: 0.063
-
Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA. 2008 Mar 05; 299(9):1036-45.
Score: 0.051
-
Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease. Am J Epidemiol. 2006 Apr 01; 163(7):589-99.
Score: 0.044
-
Correlates of serum alpha- and gamma-tocopherol in the Women's Health Initiative. Ann Epidemiol. 2001 Feb; 11(2):136-44.
Score: 0.031
-
Statins as a free pass: Body mass index and other cardiovascular risk factors among lipid-lowering medication users and nonusers in the California Men's Health Study. Prev Med. 2019 12; 129:105822.
Score: 0.028
-
Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006 Feb 08; 295(6):655-66.
Score: 0.011